These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6396067)

  • 1. [Prospects for using platinum coordination compounds possessing antitumor activity].
    Sidorik EP; Burlaka AP; Sirdorik OA; Korchevaia LM
    Eksp Onkol; 1984; 6(6):6-12. PubMed ID: 6396067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organo-platinum complexes as antitumor agents (review).
    Hill JM; Speer RJ
    Anticancer Res; 1982; 2(3):173-86. PubMed ID: 6751211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cis-platinum in the treatment of testicular and other cancers.
    Williams SD; Einhorn LH
    Adv Intern Med; 1982; 27():531-45. PubMed ID: 7041553
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of cis-platinum in solid-tumor therapy.
    Einhorn LH; Williams SD
    N Engl J Med; 1979 Feb; 300(6):289-91. PubMed ID: 366407
    [No Abstract]   [Full Text] [Related]  

  • 5. [A new cytostatic agent: cis-dischlorodiamin platinum II (DDP)].
    Gallmeier WM; Bruntsch U
    MMW Munch Med Wochenschr; 1979 May; 121(18):624-7. PubMed ID: 108586
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent updates in the clinical use of platinum compounds for the treatment of lung, breast, and genitourinary tumors and myeloma.
    Belani CP
    Semin Oncol; 2004 Dec; 31(6 Suppl 14):25-33. PubMed ID: 15726531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
    Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
    Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recurrent and 2nd line therapy in ovarian carcinoma: an overview of conventional systemic therapy modalities].
    du Bois A; Lück HJ; Meerpohl HG
    Zentralbl Gynakol; 1997; 119(7):299-323. PubMed ID: 9340970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The ototoxicity of cisplatin in the chemotherapy of tumors of the head-neck area. Our experience].
    Sbalzarini G; Malusardi G; Pandolfi C; Cerri A
    Minerva Med; 1990 May; 81(5):403-5. PubMed ID: 2377307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy of solid tumors. The role of cisplatin in today's chemotherapy].
    Kenis Y; Rozencweig M; Sanders C
    Rev Med Brux; 1983 Apr; 4(4):213-7. PubMed ID: 6683864
    [No Abstract]   [Full Text] [Related]  

  • 12. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.
    Kelland LR; Abel G; McKeage MJ; Jones M; Goddard PM; Valenti M; Murrer BA; Harrap KR
    Cancer Res; 1993 Jun; 53(11):2581-6. PubMed ID: 8388318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ototoxicity of cis-diammine glycolato platinum, 254-S].
    Horiuchi M; Miyake H; Ota K
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1327-32. PubMed ID: 1503488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin based chemotherapy in testicular cancer patients: long term platinum excretion and clinical effects.
    Hohnloser JH; Schierl R; Hasford B; Emmerich B
    Eur J Med Res; 1996 Sep; 1(11):509-14. PubMed ID: 9438151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future role of carboplatin.
    Ruckdeschel JC
    Semin Oncol; 1994 Oct; 21(5 Suppl 12):114-8. PubMed ID: 7992063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The chemotherapy of urologic neoplasms].
    Cavalli F
    Helv Chir Acta; 1978 Jul; 45(3):223-32. PubMed ID: 359509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cis-diammino-dichloro-platinum therapy of cancers; phase II therapeutic trial].
    Hayat M; Bayssas M; Brulé G; Cappelaere P; Cattan A; Chauvergne J; Clavel B; Gouveia J; Guerrin J; Pommatau E; Muggia F; Mathé G
    Nouv Presse Med; 1979 Mar; 8(15):1231-4. PubMed ID: 375187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel-ifosfamide-cisplatin as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and paclitaxel.
    Polyzos A; Kosmas C; Tsavaris N; Toufexi H; Lagadas A; Gogas H; Giannakopoulos K; Kouraklis G; Griniatsos J; Felekouras E; Tsigris C; Nikiteas N; Papadopoulos O; Giannopoulos A
    Anticancer Res; 2007; 27(3B):1645-51. PubMed ID: 17595790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How do things stand with cisplatin?
    Check W
    JAMA; 1978 Dec; 240(23):2521-2525. PubMed ID: 712945
    [No Abstract]   [Full Text] [Related]  

  • 20. "Recurrence within 6 months of platinum therapy": an adequate definition of "platinum-refractory" ovarian cancer?
    Markman M
    Gynecol Oncol; 1998 May; 69(2):91-2. PubMed ID: 9600812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.